Germany · Delayed Price · Currency is EUR Aurora Labs Statistics
Total Valuation
Aurora Labs has a market cap or net worth of EUR 10.37 million. The enterprise value is 10.26 million.
| Market Cap | 10.37M |
| Enterprise Value | 10.26M |
Important Dates
The last earnings date was Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 460.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +36.17% |
| Shares Change (QoQ) | +6.36% |
| Owned by Insiders (%) | 10.40% |
| Owned by Institutions (%) | 0.95% |
| Float | 342.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.98 |
| PB Ratio | 17.33 |
| P/TBV Ratio | 17.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.90 |
| EV / Sales | 24.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.56 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.89.
| Current Ratio | 1.28 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | -75.83 |
Financial Efficiency
Return on equity (ROE) is -262.90% and return on invested capital (ROIC) is -123.58%.
| Return on Equity (ROE) | -262.90% |
| Return on Assets (ROA) | -95.99% |
| Return on Invested Capital (ROIC) | -123.58% |
| Return on Capital Employed (ROCE) | -386.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -516,033 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -40.32% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 1,765 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aurora Labs had revenue of EUR 415,244 and -2.09 million in losses. Loss per share was -0.01.
| Revenue | 415,244 |
| Gross Profit | 182,353 |
| Operating Income | -2.57M |
| Pretax Income | -2.61M |
| Net Income | -2.09M |
| EBITDA | -2.54M |
| EBIT | -2.57M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 645,297 in cash and 533,694 in debt, giving a net cash position of 111,602.
| Cash & Cash Equivalents | 645,297 |
| Total Debt | 533,694 |
| Net Cash | 111,602 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 598,440 |
| Book Value Per Share | 0.00 |
| Working Capital | 265,697 |
Cash Flow
In the last 12 months, operating cash flow was -1.46 million and capital expenditures -101,622, giving a free cash flow of -1.56 million.
| Operating Cash Flow | -1.46M |
| Capital Expenditures | -101,622 |
| Free Cash Flow | -1.56M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 43.91% |
| Operating Margin | -618.33% |
| Pretax Margin | -628.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Aurora Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.17% |
| Shareholder Yield | -36.17% |
| Earnings Yield | -20.19% |
| FCF Yield | -15.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aurora Labs has an Altman Z-Score of -15.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.36 |
| Piotroski F-Score | 3 |